Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling-Reference-Cited by-同舟云学术

Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling

Published:2008-04-23 Issue:6 Volume:43 Page:295-299
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:

Author:

Kotze M. J.,Davis H. J.,Bissbort S.,Langenhoven E.,Brusnicky J.,Oosthuizen C. J. J.

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0004.1993.tb03821.x/fullpdf

Reference24 articles.

1. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia;Aalto-Setälä;Hum Genet,1989

2. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk;Austin;Circulation,1990

3. A new serum type system in man. The Lp system;Berg;Acta Pathol Microbiol Scand,1963

4. Impact of medical genetics on research and practices in the area of cardiovascular disease;Berg;Clin Genet,1989

5. Association of apolipoprotein B gene variants with plasma apo B and low density lipoprotein (LDL) cholesterol levels;Deeb;Hum Genet,1992

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variable expression and penetrance in Portuguese families with Familial Hypercholesterolemia with mild phenotype;Atherosclerosis Supplements;2019-03

2. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia – a preliminary report;Lipids in Health and Disease;2018-05-02

3. Homozygous Familial Hypercholesterolemia in Spain;Circulation: Cardiovascular Genetics;2016-12

4. Functional Characterization and Classification of Frequent Low-Density Lipoprotein Receptor Variants;Human Mutation;2014-11-27

5. Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer’s disease;Metabolic Brain Disease;2012-04-19